Literature DB >> 20528926

Cellular responses of A549 alveolar epithelial cells to serially collected Pseudomonas aeruginosa from cystic fibrosis patients at different stages of pulmonary infection.

Nicole A Hawdon1, Pouya Sadeghi Aval, Rebecca J Barnes, Sean K Gravelle, Jessica Rosengren, Sarah Khan, Oana Ciofu, Helle Krogh Johansen, Niels Høiby, Marina Ulanova.   

Abstract

Pseudomonas aeruginosa is the major cause of chronic pulmonary disease in cystic fibrosis (CF) patients. During chronic infection, P. aeruginosa lose certain virulence factors, transform into a mucoid phenotype, and develop antibiotic resistance. We hypothesized that these genetic and phenotypic alterations of P. aeruginosa affect the airway epithelial responses. A549 cells were infected with 27 well-characterized isolates of P. aeruginosa from CF patients obtained during longitudinal observation, or with P. aeruginosa mutant strains lacking flagella, pili, lipopolysaccharide, or pyocyanin. Pseudomonas aeruginosa isolates from the early stages of the infection exhibited high adherence to A549 cells, were readily internalized, and able to induce reactive oxygen species (ROS) production, apoptosis of infected cells, and the release of granulocyte macrophage colony-stimulating factor. Late P. aeruginosa isolates collected from patients with chronic lung infection were shown to have reduced adherence to and internalization into A549 cells compared with bacteria from patients with intermittent P. aeruginosa colonization, and induced lower production of ROS and apoptosis, but caused high proinflammatory cytokine and adhesion molecule expression. Our findings suggest that despite the loss of virulence factors during the adaptation process in the CF lung by late P. aeruginosa strains, they retain high proinflammatory abilities that likely contribute to the disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20528926     DOI: 10.1111/j.1574-695X.2010.00693.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  18 in total

1.  Membrane microdomains regulate NLRP10- and NLRP12-dependent signalling in A549 cells challenged with cigarette smoke extract.

Authors:  Dhirendra P Singh; Gagandeep Kaur; Prathyusha Bagam; Rakeysha Pinkston; Sanjay Batra
Journal:  Arch Toxicol       Date:  2018-04-06       Impact factor: 5.153

2.  Comparative physiological study of the wild type and the small colony variant of Pseudomonas aeruginosa 20265 under controlled growth conditions.

Authors:  W Sabra; A M Haddad; A-P Zeng
Journal:  World J Microbiol Biotechnol       Date:  2013-10-16       Impact factor: 3.312

3.  Immune Recognition of the Epidemic Cystic Fibrosis Pathogen Burkholderia dolosa.

Authors:  Damien Roux; Molly Weatherholt; Bradley Clark; Mihaela Gadjeva; Diane Renaud; David Scott; David Skurnik; Gregory P Priebe; Gerald Pier; Craig Gerard; Deborah R Yoder-Himes
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

4.  Pseudomonas aeruginosa thiol peroxidase protects against hydrogen peroxide toxicity and displays atypical patterns of gene regulation.

Authors:  Nawarat Somprasong; Thichakorn Jittawuttipoka; Jintana Duang-Nkern; Adisak Romsang; Pimchai Chaiyen; Herbert P Schweizer; Paiboon Vattanaviboon; Skorn Mongkolsuk
Journal:  J Bacteriol       Date:  2012-05-18       Impact factor: 3.490

Review 5.  NOD-like receptor(s) and host immune responses with Pseudomonas aeruginosa infection.

Authors:  Alaa Alhazmi
Journal:  Inflamm Res       Date:  2018-01-20       Impact factor: 4.575

6.  Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient.

Authors:  Arianna Pompilio; Valentina Crocetta; Dipankar Ghosh; Malabika Chakrabarti; Giovanni Gherardi; Luca Agostino Vitali; Ersilia Fiscarelli; Giovanni Di Bonaventura
Journal:  Front Microbiol       Date:  2016-09-30       Impact factor: 5.640

7.  Blue light treatment of Pseudomonas aeruginosa: Strong bactericidal activity, synergism with antibiotics and inactivation of virulence factors.

Authors:  Grzegorz Fila; Anna Kawiak; Mariusz Stanislaw Grinholc
Journal:  Virulence       Date:  2016-10-20       Impact factor: 5.882

8.  Budesonide suppresses pulmonary antibacterial host defense by down-regulating cathelicidin-related antimicrobial peptide in allergic inflammation mice and in lung epithelial cells.

Authors:  Peng Wang; Xiaoyun Wang; Xiaoqiong Yang; Zhigang Liu; Min Wu; Guoping Li
Journal:  BMC Immunol       Date:  2013-02-06       Impact factor: 3.615

9.  Staphylococcus aureus Inhibits IL-8 Responses Induced by Pseudomonas aeruginosa in Airway Epithelial Cells.

Authors:  Samuel M Chekabab; Richard J Silverman; Shantelle L Lafayette; Yishan Luo; Simon Rousseau; Dao Nguyen
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

10.  Characterization of nontypable Haemophilus influenzae isolates recovered from adult patients with underlying chronic lung disease reveals genotypic and phenotypic traits associated with persistent infection.

Authors:  Junkal Garmendia; Cristina Viadas; Laura Calatayud; Joshua Chang Mell; Pau Martí-Lliteras; Begoña Euba; Enrique Llobet; Carmen Gil; José Antonio Bengoechea; Rosemary J Redfield; Josefina Liñares
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.